BRL-50481

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBRL-50481
Drug Alias NamePDE 7 inhibitors (GSK/Imperial/Calgary)PDE 7 inhibitors (GlaxoSmithKline/Imperial/Calgary)BRL-50481
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 7 inhibitors
TargetsPhosphodiesterase 7
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A